DermatologyEducation

Improving patient care by providing clinical expertise and practical guidance to dermatologists worldwide

[AADmember @AADmember]

Is atopic #dermatitis actually a systemic #inflammatory disorder? #DermWorld - https://t.co/IZemK4SMSf

[DermatologyEducation @dermaedu]

1-year phase 3 data for concomitant #dupilumab and topical corticosteriod treatment of #AtopicDermatitis published: https://t.co/A8LB5dtsiA

[DermatologyEducation @dermaedu]

Phase 3 data for #adalimumab vs #methotrexate in children and adolescents with plaque #psoriasis are published
https://t.co/KOWxetwP5x

[DermatologyEducation @dermaedu]

Phase 3 data for #adalimumab vs #methotrexate in children and adolescents with plaque #psoriasis are published
https://t.co/KOWxetwP5x

[DermatologyEducation @dermaedu]

1-year phase 3 data for concomitant #dupilumab and topical corticosteriod treatment of #AtopicDermatitis published: https://t.co/A8LB5dtsiA

[DermatologyEducation @dermaedu]

Results from a phase 2 head-to-head trial of #risankizumab vs #ustekinumab in #psoriasis have been published
https://t.co/2MYNUvZ3ld

[DermatologyEducation @dermaedu]

Results from a phase 2 head-to-head trial of #risankizumab vs #ustekinumab in #psoriasis have been published
https://t.co/2MYNUvZ3ld

[DermatologyEducation @dermaedu]

FDA approves #biosimilar for #infliximab
https://t.co/0rMC6qp0om

[DermatologyEducation @dermaedu]

FDA approves addition of #fingernail psoriasis to the prescribing information for #adalimumab (#Humira) for patients with plaque #psoriasis

[DermatologyEducation @dermaedu]

FDA approves addition of #fingernail psoriasis to the prescribing information for #adalimumab (#Humira) for patients with plaque #psoriasis

[DermatologyEducation @dermaedu]

#dupilumab (#Dupixent) approved to treat adults with moderate-to-severe #eczema (#atopic dermatitis)

[DermatologyEducation @dermaedu]

Watch Dr Bruce Strober provide expert insight into evaluation of #biosimilars https://t.co/iVUVCUOYUW

[DermatologyEducation @dermaedu]

Watch Dr Gordon, expert dermatologist, discuss serious infections and hospitalization in patients with #psoriasis https://t.co/AGSEdHpYDD

[DermatologyEducation @dermaedu]

Expert discussion of the latest developments in management of #HidradenitisSuppurativa https://t.co/mh6GWVadII

[DermatologyEducation @dermaedu]

Watch Dr Kenneth Gordon provide expert insight into the use of #ixekizumab to treat patients with #psoriasis https://t.co/DHYrFfF5OV

[DermatologyEducation @dermaedu]

Watch Dr Kristian Reich, expert dermatologist, discuss the safety of #biologics in the treatment of #psoriasis https://t.co/MORa4Oc4He

[DermatologyEducation @dermaedu]

Watch our expert Dr Bruce Strober discuss the clinical relevance of #immunogenicity to #biologics https://t.co/9cHjxkyY0v

[DermatologyEducation @dermaedu]

FDA approves #Siliq (#brodalumab) to treat plaque #psoriasis
#dermatology

[DermatologyEducation @dermaedu]

Watch Dr Gordon, expert dermatologist, discuss work productivity in patients with #psoriasis receiving treatment https://t.co/2xQU52wsPk

[DermatologyEducation @dermaedu]

Watch Dr Bruce Strober provide expert insight into evaluation of #biosimilars https://t.co/tg9aVaM4Mi
#psoriasis #dermatology